Cover Image
市場調查報告書

美國:液態切片 (液體切片檢查) 檢驗市場 & 檢查數量分析 2020年

United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020

出版商 Renub Research 商品編碼 349638
出版日期 內容資訊 英文 79 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國:液態切片 (液體切片檢查) 檢驗市場 & 檢查數量分析 2020年 United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020
出版日期: 2016年01月12日 內容資訊: 英文 79 Pages
簡介

本報告提供急速成長的美國液態切片 (液體切片檢查) 市場相關的總括性調查、美國的5大癌症市場區隔的液態切片檢驗市場及數量分析、近幾年的發展趨勢、主要的契約,及市場促進要素與課題彙整。

第1章 摘要整理

第2章 美國:液態切片市場預測

  • 液態切片市場
  • 液態切片篩檢檢驗市場
  • 液態切片治療監測市場

第3章 美國:液態切片的檢驗數預測

  • 液態切片檢查數量
  • 液態切片篩檢檢查數量
  • 液態切片治療監測檢查數量

第4章 美國:液態切片市場佔有率預測

  • 液態切片市場佔有率:各手法
  • 液態切片篩檢市場佔有率:各癌症類型
  • 液態切片治療監測市場佔有率:各癌症類型

第5章 美國:液態切片市場 & 檢查數量:各癌症種類的預測

  • 肺癌的液態切片市場、檢查數量
  • 肺癌
  • 乳癌
  • 大腸癌
  • 前列腺癌
  • 肝癌

第6章 美國:液態切片篩檢市場 & 檢查數量:各癌症種類的預測

  • 肺癌
  • 乳癌
  • 大腸癌
  • 前列腺癌
  • 肝癌

第7章 美國:液態切片治療監測市場 & 檢查數量:各癌症種類的預測

  • 肺癌
  • 乳癌
  • 大腸癌
  • 前列腺癌
  • 肝癌
  • 其他癌症

第8章 液態切片市場:近幾年的發展趨勢

第9章 液態切片市場:主要契約分析

第10章 液態切片市場:促進要素

  • 即時評估、便利性及準確度
  • 微創切片檢查技術的需求增加
  • 技術進步、個別療法

第11章 液態切片市場:課題

圖表

目錄

Overview

Liquid Biopsy Tests are emerging as a viable alternative to traditional methods for cancer screening. A liquid biopsy is a new type of blood test that has the potential to transform cancer treatment. Using this methodology, physicians avoid the traditional surgical and needle biopsies they use to determine the existence of cancer in patients. In United States Liquid Biopsy market; Screening Test is likely to capture major chunk of the market compared to Monitoring Market. It is anticipated that Liquid Biopsy Testing will be more helpful for monitoring cancer treatment and status after diagnosis than in screening for a cancer that may be years or even decades in the making and not otherwise detectable.

United States - Liquid Biopsy Potential Screening Market Analysis: In the United States liquid biopsy screening market, prostate cancer is the most popular segment. Lung cancer liquid biopsy screening stands at the last spot.

United States - Liquid Biopsy Potential Treatment Monitoring Market Analysis: In the United States liquid biopsy treatment monitoring market, breast cancer is the leading segment. Liver cancer stands at the fifth spot.

Renub Research report titled “United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020” provides a comprehensive assessment of the fast-evolving, high-growth of Liquid Biopsy Market. This 79 page report with 41 Figures analyses the United States Liquid Biopsy Test Market and Volume by 5 Top Cancer Segment, Recent developments, Major Deals along with the driving factors and challenges for Liquid Biopsy Market.

The United States Liquid Biopsy Potential Market has been analyzed from two view points

1. United States Liquid Biopsy Potential Screening Market & Test Volume (2015 - 2020)

The Top 5 Cancer Segments covered are:

  • 1. Lung Cancer
  • 2. Breast Cancer
  • 3. Colorectal Cancer
  • 4. Prostate Cancer
  • 5. Liver Cancer

2. United States Liquid Biopsy Potential Treatment Monitoring Market & Test Volume (2015 - 2020)

The Top 6 Cancer Segments covered are:

  • 1. Lung Cancer
  • 2. Breast Cancer
  • 3. Colorectal Cancer
  • 4. Prostate Cancer
  • 5. Liver Cancer
  • 6. Other Cancers

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. United States - Liquid Biopsy Potential Market (2015-2020)

  • 2.1. United States - Liquid Biopsy Potential Market
  • 2.2. United States - Liquid Biopsy Screening Potential Market
  • 2.3. United States - Liquid Biopsy Treatment Monitoring Potential Market

3. United States - Liquid Biopsy Potential Test Volume (2015-2020)

  • 3.1. United States - Liquid Biopsy Potential Test Volume
  • 3.2. United States - Liquid Biopsy Potential Screening Test Volume
  • 3.3. United States - Liquid Biopsy Potential Treatment Monitoring Test Volume

4. United States - Liquid Biopsy Potential Market Share (2015-2020)

  • 4.1. United States - Liquid Biopsy Potential Market Share by Method
  • 4.2. United States - Liquid Biopsy Screening Potential Market Share by Cancer Types
  • 4.3. United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types

5. United States - Liquid Biopsy Potential Market & Test Volume by Cancer Types (2015-2020)

  • 5.1. United States - Liquid Biopsy Lung Cancer Potential Market & Test Volume
    • 5.1.1. United States - Liquid Biopsy Lung Cancer Potential Market
    • 5.1.2. United States - Liquid Biopsy Lung Cancer Potential Test Volume
  • 5.2. United States - Liquid Biopsy Breast Cancer Potential Market & Test Volume
    • 5.2.1. United States - Liquid Biopsy Breast Cancer Potential Market
    • 5.2.2. United States - Liquid Biopsy Breast Cancer Potential Test Volume
  • 5.3. United States - Liquid Biopsy Colorectal Cancer Potential Market & Test Volume
    • 5.3.1. United States - Liquid Biopsy Colorectal Cancer Potential Market
    • 5.3.2. United States - Liquid Biopsy Colorectal Cancer Potential Test Volume
  • 5.4. United States - Liquid Biopsy Prostate Cancer Potential Market & Test Volume
    • 5.4.1. United States - Liquid Biopsy Prostate Cancer Potential Market
    • 5.4.2. United States - Liquid Biopsy Prostate Cancer Potential Test Volume
  • 5.5. United States - Liquid Biopsy Liver Cancer Potential Market & Test Volume
    • 5.5.1. United States - Liquid Biopsy Liver Cancer Potential Market
    • 5.5.2. United States - Liquid Biopsy Liver Cancer Potential Test Volume

6. United States - Liquid Biopsy Screening Potential Market & Test Volume by Cancer Types (2015-2020)

  • 6.1. United States - Liquid Biopsy Lung Cancer Screening Potential Market & Test Volume
    • 6.1.1. United States - Liquid Biopsy Lung Cancer Screening Potential Market
    • 6.1.2. United States - Liquid Biopsy Lung Cancer Screening Potential Test Volume
  • 6.2. United States - Liquid Biopsy Breast Cancer Screening Potential Market & Test Volume
    • 6.2.1. United States - Liquid Biopsy Breast Cancer Screening Potential Market
    • 6.2.2. United States - Liquid Biopsy Breast Cancer Screening Potential Test Volume
  • 6.3. United States - Liquid Biopsy Colorectal Cancer Screening Potential Market & Test Volume
    • 6.3.1. United States - Liquid Biopsy Colorectal Cancer Screening Potential Market
    • 6.3.2. United States - Liquid Biopsy Colorectal Cancer Screening Potential Test Volume
  • 6.4. United States - Liquid Biopsy Prostate Cancer Screening Potential Market & Test Volume
    • 6.4.1. United States - Liquid Biopsy Prostate Cancer Screening Potential Market
    • 6.4.2. United States - Liquid Biopsy Prostate Cancer Screening Potential Test Volume
  • 6.5. United States - Liquid Biopsy Liver Cancer Screening Potential Market & Test Volume
    • 6.5.1. United States - Liquid Biopsy Liver Cancer Screening Potential Market
    • 6.5.2. United States - Liquid Biopsy Liver Cancer Screening Potential Test Volume

7. United States - Liquid Biopsy Treatment Monitoring Potential Market & Test Volume by Cancer Types (2015-2020)

  • 7.1. United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market & Test Volume
    • 7.1.1. United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market
    • 7.1.2. United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Test Volume
  • 7.2. United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market & Test Volume
    • 7.2.1. United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market
    • 7.2.2. United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Test Volume
  • 7.3. United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market & Test Volume
    • 7.3.1. United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market
    • 7.3.2. United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Test Volume
  • 7.4. United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market & Test Volume
    • 7.4.1. United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market
    • 7.4.2. United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Test Volume
  • 7.5. United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market & Test Volume
    • 7.5.1. United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market
    • 7.5.2. United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Test Volume
  • 7.6. United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market & Test Volume
    • 7.6.1. United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market
    • 7.6.2. United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Test Volume

8. Liquid Biopsy Market-Recent Development

9. Liquid Biopsy Market-Major Deals Analysis

10. Liquid Biopsy Market-Driving Factors

  • 10.1. Real-Time Evaluation, Convenient and Accuracy
  • 10.2. Increasing Demand for Minimally-Invasive Biopsy Techniques
  • 10.3. Technical Advancement & Personalized Therapies

11. Liquid Biopsy Market-Challenges

  • 11.1. Barriers for Liquid Biopsies
    • 11.1.1. Comparatively Low Concentration of Molecular Biomarkers in Body Fluids
    • 11.1.2. Low Concentration of Target DNA in A Plasma Sample
    • 11.1.3. Proper Handling and Storage of the Samples Critical

List of Figures:

  • Figure 2-1: United States - Liquid Biopsy Potential Market (Million US$), 2015 - 2020
  • Figure 2-2: United States - Liquid Biopsy Screening Potential Market (Million US$), 2015 - 2020
  • Figure 2-3: United States - Liquid Biopsy Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 3-1: United States - Liquid Biopsy Potential Test Volume (Number), 2015 - 2020
  • Figure 3-2: United States - Liquid Biopsy Potential Screening Test Volume (Number), 2015 - 2020
  • Figure 3-3: United States - Liquid Biopsy Potential Treatment Monitoring Test Volume (Number), 2015 - 2020
  • Figure 4-1: United States-Method Wise Liquid Biopsy Potential Market Share (Percent), 2015 - 2020
  • Figure 4-2: United States - Liquid Biopsy Screening Potential Market Share by Cancer Types (Percent), 2015 - 2020
  • Figure 4-3: United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types (Percent), 2015 - 2020
  • Figure 5-1: United States - Liquid Biopsy Lung Cancer Potential Market (Million US$), 2015 - 2020
  • Figure 5-2: United States - Liquid Biopsy Lung Cancer Potential Test Volume (Number), 2015 - 2020
  • Figure 5-3: United States - Liquid Biopsy Breast Cancer Potential Market (Million US$), 2015 - 2020
  • Figure 5-4: United States - Liquid Biopsy Breast Cancer Potential Test Volume (Number), 2015 - 2020
  • Figure 5-5: United States - Liquid Biopsy Colorectal Cancer Potential Market (Million US$), 2015 - 2020
  • Figure 5-6: United States - Liquid Biopsy Colorectal Cancer Potential Test Volume (Number), 2015 - 2020
  • Figure 5-7: United States - Liquid Biopsy Prostate Cancer Potential Market (Million US$), 2015 - 2020
  • Figure 5-8: United States - Liquid Biopsy Prostate Cancer Potential Test Volume (Number), 2015 - 2020
  • Figure 5-9: United States - Liquid Biopsy Liver Cancer Potential Market (Million US$), 2015 - 2020
  • Figure 5-10: United States - Liquid Biopsy Liver Cancer Potential Test Volume (Number), 2015 - 2020
  • Figure 6-1: United States - Liquid Biopsy Lung Cancer Screening Potential Market (Million US$), 2015 - 2020
  • Figure 6-2: United States - Liquid Biopsy Lung Cancer Screening Potential Test Volume (Number), 2015 - 2020
  • Figure 6-3: United States - Liquid Biopsy Breast Cancer Screening Potential Market (Million US$), 2015 - 2020
  • Figure 6-4: United States - Liquid Biopsy Breast Cancer Screening Potential Test Volume (Number), 2015 - 2020
  • Figure 6-5: United States - Liquid Biopsy Colorectal Cancer Screening Potential Market (Million US$), 2015 - 2020
  • Figure 6-6: United States - Liquid Biopsy Colorectal Cancer Screening Potential Test Volume (Number), 2015-2020
  • Figure 6-7: United States - Liquid Biopsy Prostate Cancer Screening Potential Market (Million US$), 2015 - 2020
  • Figure 6-8: United States - Liquid Biopsy Prostate Cancer Screening Potential Test Volume (Number), 2015 - 2020
  • Figure 6-9: United States - Liquid Biopsy Liver Cancer Screening Potential Market (Million US$), 2015 - 2020
  • Figure 6-10: United States - Liquid Biopsy Liver Cancer Screening Potential Test Volume (Number), 2015-2020
  • Figure 7-1: United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-2: United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
  • Figure 7-3: United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-4: United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
  • Figure 7-5: United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-6: United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
  • Figure 7-7: United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-8: United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
  • Figure 7-9: United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-10: United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
  • Figure 7-11: United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-12: United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Test Volume (Number), 2015-2020
Back to Top